RS

Ramya Sri Sura

Active Director Director DIN 08066611
DIN 08066611 First appointment Feb 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Feb 2018
Shareholding value •••• Premium profile

About Ramya Sri Sura

Data last updated:

Ramya Sri Sura is a Director at Jeevas Biotech Private Limited (since 2025), Director at Norcal It Private Limited (since 2018) and Director at Sura Pharma Labs Private Limited (since 2024). The companies operate in Healthcare and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹23.6 Lakh; the largest is Jeevas Biotech Private Limited at ₹16.5 Lakh (FY 2025). Earlier, Ramya Sri Sura was a Director at Pharma Learnbay Private Limited (from 2019).

DIN 08066611
Primary Designation Director
Industry Healthcare
First Appointment 09 Feb 2018
Oldest Company Age 12 yrs
Largest company Jeevas Biotech Private Limited · ₹16.5 Lakh (FY 2025)
Combined revenue ₹23.6 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jeevas Biotech Private Limited U24230TG2022PTC161746
Director25 Jan 20252022₹16.5 Lakh (FY 2025)Active
Norcal It Private Limited U72400TG2013PTC091405
Director09 Feb 20182013₹7.1 Lakh (FY 2020)Active
Sura Pharma Labs Private Limited U85500TS2024PTC192263
Director24 Dec 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharma Learnbay Private Limited U80902TG2019PTC137269
Director02 Dec 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ramya Sri Sura

NameDINCompanyDesignation
Chippa Priyanka10698675Jeevas Biotech Private LimitedAdditional Director
Janamma Mylarapu10698645Jeevas Biotech Private LimitedAdditional Director
Rajani Soora08066605Jeevas Biotech Private Limited , Norcal It Private Limited and 1 moreManaging Director
Rasul Saheb Shaik08705648Norcal It Private LimitedDirector

Directorship timeline

Open interactive timeline →
Norcal It Private Limited
Pharma Learnbay Private Limited
Jeevas Biotech Private Limited
Sura Pharma Labs Private Limited
Premium access

Shareholding and investment profile for Ramya Sri Sura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramya Sri Sura

Ramya Sri Sura currently holds 3 directorships: Jeevas Biotech Private Limited (Director, since 25 Jan 2025, revenue ₹16.5 Lakh (FY 2025)); Norcal It Private Limited (Director, since 09 Feb 2018, revenue ₹7.1 Lakh (FY 2020)); Sura Pharma Labs Private Limited (Director, since 24 Dec 2024).

Ramya Sri Sura was first appointed on 09 Feb 2018 as Director at Norcal It Private Limited. The most recent appointment on record is 25 Jan 2025 at Jeevas Biotech Private Limited.

The 2 current companies of Ramya Sri Sura that report revenue have a combined latest revenue of ₹23.6 Lakh: Jeevas Biotech Private Limited ₹16.5 Lakh (FY 2025); Norcal It Private Limited ₹7.1 Lakh (FY 2020).

Ramya Sri Sura held 1 earlier board appointment: Pharma Learnbay Private Limited (Director, from 02 Dec 2019).

The current boards of Ramya Sri Sura's companies include Chippa Priyanka (Jeevas Biotech Private Limited), Janamma Mylarapu (Jeevas Biotech Private Limited), Rajani Soora (Jeevas Biotech Private Limited), Rasul Saheb Shaik (Norcal It Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available